Abstract
The four MEF2 transcription factors (MEF2A, -B, -C, and -D) regulate differentiation and calcium-dependent gene expression in muscle cells. We generated mice deficient in MEF2A, the predominant Mef2 gene product expressed in post-natal cardiac muscle. Most mice lacking Mef2a died suddenly within the first week of life and exhibited pronounced dilation of the right ventricle, myofibrillar fragmentation, mitochondrial disorganization and activation of a fetal cardiac gene program. The few Mef2a−/− mice that survived to adulthood also showed a deficiency of cardiac mitochondria and susceptibility to sudden death. Paradoxically, MEF2 transcriptional activity, revealed by the expression of a MEF2-dependent transgene, was enhanced in the hearts of Mef2a-mutant mice, reflecting the transcriptional activation of residual MEF2D. These findings reveal specific roles for MEF2A in maintaining appropriate mitochondrial content and cyto-architectural integrity in the post-natal heart and show that other MEF2 isoforms cannot support these activities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wallace, D. Mitochondrial defects in cardiomyopathy and neuromuscular disease. Amer. Heart J. 139, S70–S85 (2000).
Towbin, J.A. & Lipshultz, S.E. Genetics of neonatal cardiomyopathy. Curr. Op. Card. 14, 250–262 (1999).
Williams, R.S. Cardiac involvement in mitochondrial disease, and vice versa. Circulation 91, 1266–1268 (1995).
Wallace, D.C. Mitochondrial diseases in man and mouse. Science. 283, 1482–1488 (1999).
Wang, J. et al. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nature Genet. 21, 133–137 (1999).
Li, Y. et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet. 11, 376–381 (1995).
Graham, B.H. et al. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nature Genet. 16, 226–234 (1997).
Lehman, J.J. et al. Peroxisome proliferator-activated γ coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106 (7), 847–856.
Black, B. & Olson, E.N. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Ann. Rev. Cell Dev. Biol. 14, 167–196 (1998).
McKinsey, T., Zhang, C. & Olson, E.N. MEF2: A calcium-dependent regulator of cell division, differentiation, and death. Trends Biochem. Sci. 27, 40–47 (2002).
Lesnefsky, E.J., Moghaddas, S., Tandler, B., Kerner, J. & Hoppel, C.L. Mitochondrial dysfunction in cardiac disease: Ischemia-reperfusion, aging, and heart failure. J. Mol. Cell. Cardiol. 33, 1065–1089 (2001).
Bonnet, D. et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 100, 2248–2253 (1999).
Ibdah, J.A. et al. Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J. Clin. Invest. 107, 1403–1409 (2001).
Muscat, G.E., Perry, S., Prentice, H. & Kedes, L. The human skeletal α-actin gene is regulated by a muscle-specific enhancer that binds three nuclear factors. Gene Expr. 2, 111–126 (1992).
Woronicz, J.D. et al. Regulation of the Nur 77 orphan steroid receptor in activation-induced apoptosis. Mol. Cell Biol. 15, 6364–6376 (1995).
Morin, S., Charron, F., Robitaille, L. & Nemer, M. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 19, 2046–2055 (2000).
Ruiz-Lozano, P. et al. Energy deprivation and a deficiency in downstream metabolic target genes during the onset of embryonic heart failure in RXRα−/− embryos. Development 125, 533–544 (1998).
Naya, F.J., Wu, C., Richardson, J.A., Overbeek, P. & Olson, E.N. Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development. 126, 2045–2052 (1999).
Passier, R, et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105, 1395–1406 (2000).
Zhang, C.L. et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479–488 (2002).
Michael, L.F. et al. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc. Natl. Acad. Sci. USA 27, 3820–3825 (2001).
Marin-Garcia, J., Goldenthal, M.J. & Moe, G.W. Mitochondrial pathology in cardiac failure. Cardiovasc. Res. 49, 17–26 (2001).
Antozzi, C. & Zeviani, M. Cardiomyopathies in disorders of oxidative metabolism. Cardiovasc. Res. 35, 184–199 (1997).
Marin-Garcia, J. & Goldenthal, M.J. Mitochondrial cardiomyopathy: Molecular and Biochemical Analysis. Pediatr. Cardiol. 18, 251–260 (1997).
Zipes, D.P. & Wellens, H.J.J. Sudden cardiac death. Circulation 98, 2334–2351 (1998).
Spooner, P.M. et al. Sudden cardiac death, genes, and arrhythmogenesis. Circulation 103, 2361–2364 (2001).
Keating, M.T. & Sanguinetti, M.C. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104, 569–580 (2001).
Kuo, H.C. et al. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 107, 801–813 (2001).
McKinsey, T.A., Zhang, C.L. & Olson, E.N. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11, 497–504 (2001).
Lin, Q., Schwarz, J., Bucana, C. & Olson, E.N. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276, 1404–1407 (1997).
Lin, Q. et al. Requirement of the MADS box transcription factor MEF2C for vascular development. Development 125, 4565–4574 (1998).
Bossy-Wetzel, E. & Green, D.R. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J. Biol. Chem. 274, 17484–17490 (1999).
Acknowledgements
We thank A. Tizenor for assistance with graphics and members of the Olson lab for advice throughout the course of this work. This study was supported by grants from the NIH, the Texas Advanced Technology Program, and the Donald W. Reynolds Foundation (to E.N.O.). F.J.N. was supported by a postdoctoral fellowship from the NIH
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Naya, F., Black, B., Wu, H. et al. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat Med 8, 1303–1309 (2002). https://doi.org/10.1038/nm789
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm789
This article is cited by
-
The MEF2A transcription factor interactome in cardiomyocytes
Cell Death & Disease (2023)
-
Comprehensive analysis of pre-mRNA alternative splicing regulated by m6A methylation in pig oxidative and glycolytic skeletal muscles
BMC Genomics (2022)
-
Identification of Nrf2-responsive microRNA networks as putative mediators of myocardial reductive stress
Scientific Reports (2021)
-
MEF2A alters the proliferation, inflammation-related gene expression profiles and its silencing induces cellular senescence in human coronary endothelial cells
BMC Molecular Biology (2019)
-
A reference map of murine cardiac transcription factor chromatin occupancy identifies dynamic and conserved enhancers
Nature Communications (2019)